avidbio.com - CDMO Total Company Value-to-Revenue Ratio

Public company logo of avidbio.com (CDMO)

Geopolitical instability and export restrictions create risks for Avid Bioservices, Inc. (CDMO) raw material supplies. The EV/Sales multiple on the current GURU.Markets platform chart illustrates valuation dynamics, where serves as the parameter's baseline value. Experienced management is effectively expanding production capacity, while financial stability is supported by steady biotech sector demand for protein production.

CDMO: Avid Bioservices Inc Company Value to Revenue 07/04/2022 - 11/20/2026

Avid Bioservices Inc - analytical breakdowns and key metrics (CDMO)

Initial company analysis:CDMO, avidbio.com
Flagship merchandise of Avid Bioservices, Inc

This indicator measures the total enterprise value, including debt and subtracting cash, relative to annual sales to determine the asset's market overvaluation. By analyzing the EV/Revenue ratio, an investor assesses the capitalization efficiency of the Avid Bioservices, Inc. (CDMO) service model, where the diversification of the client portfolio within the contract drug manufacturing sector mitigates risks and stabilizes the company's fundamental value.